Registry data from the British Society for Rheumatology Biologics Registry for RA (BSRBR-RA) [29], including 14 436 individuals prescribed biologics, compared remission and low disease activity (LDA) in patients treated with TNF inhibitors (TNFis). This evidence concerns the gene TNF and rheumatoid arthritis.